InMode Ltd.

INMD Healthcare Medical Devices

InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.

14.16 0.16 −1.12%
Market cap
$824.0M
P/E
11.3×
Fwd P/E
11.8×
Dividend yield
—
F-score
4/9
Altman Z
10.45
Beneish M
−2.25
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Revenue
370.50 394.82 492.05 454.27 357.57 206.11 156.36 100.16 53.46
Revenue Growth
(6.16%) (19.76%) 8.32% 27.05% 73.49% 31.81% 56.11% 87.37% (46.63%)
Gross Profit
290.97 317.07 411.34 380.79 303.97 175.26 136.12 85.11 44.40
Operating Income
85.39 112.53 195.66 197.85 167.48 72.84 59.62 23.49 8.95
EBT
110.33 143.47 217.27 201.47 168.00 76.13 62.04 23.63 9.80
Income after Tax
93.83 181.28 197.92 161.52 165.07 75.03 61.16 22.37 8.82
Net Income Common
93.83 181.28 197.92 161.52 164.97 75.03 61.15 22.37 8.82
EPS (Diluted)
1.43 2.25 2.30 1.89 1.92 0.89 0.80 0.32 0.15
Shares (Diluted, Weighted)
65.45 80.60 85.95 85.40 86.02 84.18 76.12 70.01 59.34
Gross Margin
78.54% 80.31% 83.60% 83.82% 85.01% 85.03% 87.06% 84.97% 83.06%
EBIT Margin
23.05% 28.50% 39.76% 43.55% 46.84% 35.34% 38.13% 23.45% 16.74%
Net Profit Margin
25.33% 45.91% 40.22% 35.56% 46.14% 36.40% 39.11% 22.33% 16.50%
Free Cash Flow Margin
22.75% 33.43% 35.79% 39.62% 48.65% 38.21% 39.34% 36.45% 26.98%
EBITDA
86.08 113.26 196.28 198.53 167.99 73.26 59.92 23.67 9.15
EBIT
85.39 112.53 195.66 197.85 167.48 72.84 59.62 23.49 8.95

Show all line items

In millions of $ except per-share values · columns are period end dates